Chassis/Cell-Free Systems
Introduction
Cell-Free Systems (CFS) involve the in-vitro expression of genes into proteins. These systems can serve as a compatible chassis for the various parts and devices from the Registry of Standard Biological Parts.
Coupled transcription-translation systems usually combine a bacteriophage RNA polymerase and promoter with eukaryotic or prokaryotic extracts. In addition, the PURE system has been developed as a reconstituted CFS for synthesizing proteins using recombinant elements 1.
Advantages and disadvantages of CFS
Non-infectious because of non-proliferative nature | Short expression lifespan since system cannot replicate |
Process is quick and simple requiring only preparation of cell extract and feeding solution and subsequent addition of DNA template | Expensive because of the constant need for nutrient and energy supply |
Quality control can be achieved easily using modified reaction conditions such as addition of accessory elements or inhibitory factors | Less characterization and experience of use in the laboratories compared to E. coli |
Specifications for CFS characterization
Several parameters are identified to help us understand the advantages and disadvantages associated with using a particular chassis.
Properties | |
Optimum temperature | Temperature at which expression rate reaches a maximum value. |
Peak time | Measure of time from start of reaction to the point when expression rate reaches the maximum value. |
Product stability | Measure of the half-life of a given protein (e.g. GFP) synthesized in the chassis. |
Expression capacity | Measure of the total expression of a chassis for a given DNA construct template. This should take into account the degradation of synthesized protein. |
Expression lifespan | Measure of time that expression occurs for a given DNA construct template until protein degradation overrides protein synthesis. |
Cell-Free Systems investigated
Please click on each system for its individual characterization.
Homemade E. coli S30 | Commercial E. coli S30 | Commercial E. coli T7 S30 | Vesicle-encapsulation |
Different compartmentalization strategies
Batch-mode | Transcription-translation reaction is carried out in bulk solution. |
Continuous-exchange | Transcription-translation reaction is separated from feeding solution by a dialysis membrane. |
Vesicle-encapsulated | The reaction is separated from feeding solution by a phospholipid bilayer. More reliable exchange of materials is established by inserting a non-specific pore protein into the phospholipid bilayer.2 |
DNA constructs selected for CFS characterization
- A simple constitutive gene expression device that reguires an E. coli RNA polymerase BBa_I13522
- A simple constitutive gene expression device that requires a T7 bacteriophage RNA polymerase BBa_R0085
- An inducible gene expression device that is well-characterized in the registry BBa_T9002
References
<biblio>
- 1 pmid=16076456
- 2 pmid=16224117
- 3 pmid=14559971
- 4 pmid=15183761
</biblio>